Page 22 of 93
Previous Page     Next Page        Smaller fonts | Larger fonts     Go back to the flash version

“Cell phones have penetrated all corners of the planet,” said Holomic CEO Neven Karlovac. “We plan to take advantage of their global reach to provide a product that will meet a real medical need.”

http://www1.cnsi.ucla.edu/index http://youtu.be/ZI2BPhRCfAo http://innovate.ee.ucla.edu/

IdaTech Ltd (IdaTech) has closed its transaction with Ballard Power Systems (TSX: BLD; NASDAQ: BLDP). In that transaction, IdaTech granted a non- exclusive technology license and sold key assets of its Telecom Backup Power business to Ballard, including IdaTech’s name and trademarks. Consequently, the company will announce a change to its name. Signifying a long term commitment to the success of the transaction, payment will be made through the issuance of Ballard common shares, which will be transferred to Investec, IdaTech’s principal funder. Ballard has worked closely with IdaTech over the past several years, supplying fuel cell stacks for its systems.

http://www.idatech.com/

 Illumina, Inc. (NASDAQ: ILMN) has acquired Cambridge, UK-based BlueGnome Ltd. for an undisclosed sum. BlueGnome, now a wholly owned subsidiary of Illumina, is a leading provider of solutions for the screening of genetic abnormalities associated with developmental delay, cancer, and infertility. Moreover, llumina was awarded a contract from the US Food and Drug Administration (FDA) to provide the agency with MiSeq sequencing systems and reagents for conducting whole genome analysis on produce and produce-related environmental Salmonella and shigatoxigenic E. coli isolates. The contract is worth up to $17 million over a period of five years. Illumina also announced five initial TruSight content sets for use in next-generation sequencing (NGS) in laboratory settings. Customers can immediately leverage this content to develop their own tests, and in the first half of 2013 will have the additional capability to augment the sets with custom content. Illumina also launched the Infinium HumanCoreBeadChip family of products.

Illumina also announced that Magistrate Judge Elizabeth D. LaPorte of the US District Court for the Northern District of California granted a motion for summary judgment of invalidity filed by Complete Genomics, Inc. against certain claims of Illumina‘s US Patent No. 6,306,597.

http://www.illumina.com

Infineon Technologies AG (OTCQX: IFNNY) introduced its first single-chip radar solutions for applications in industrial and commercial sensing. Based on a SiGe process technology and operating in the 24GHz ISM band (24.0 to 24.25GHz), the new product family features the highest integration radar system-on-chip transceivers in the market and a companion receive only chip, which collectively provide system designers with the flexibility to achieve cost and performance targets in a diverse range of applications.

 

Previous arrowPrevious Page     Next PageNext arrow        Smaller fonts | Larger fonts     Go back to the flash version
1  |  2  |  3  |  4  |  5  |  6  |  7  |  8  |  9  |  10  |  11  |  12  |  13  |  14  |  15  |  16  |  17  |  18  |  19  |  20  |  21  |  22  |  23  |  24  |  25  |  26  |  27  |  28  |  29  |  30  |  31  |  32  |  33  |  34  |  35  |  36  |  37  |  38  |  39  |  40  |  41  |  42  |  43  |  44  |  45  |  46  |  47  |  48  |  49  |  50  |  51  |  52  |  53  |  54  |  55  |  56  |  57  |  58  |  59  |  60  |  61  |  62  |  63  |  64  |  65  |  66  |  67  |  68  |  69  |  70  |  71  |  72  |  73  |  74  |  75  |  76  |  77  |  78  |  79  |  80  |  81  |  82  |  83  |  84  |  85  |  86  |  87  |  88  |  89  |  90  |  91  |  92  |  93